CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a novel gene therapy approach for Alzheimer's disease by targeting brain endothelial cells to enhance the clearance of Amyloid-β. Utilizing super-selective nanocarriers, the therapy seeks to improve treatment efficacy and potentially halt disease progression in patients.
Alzheimer disease (AD) is the most common cause of dementia (60-80% of cases) with a prevalence near 50 million people.
There is no cure available and there are only two classes of approved drugs that are effective in treat some of the cognitive symptoms and potentially delay the clinical decline.
Despite the considerable progress achieved in the research of best performing disease-modifying agents, the main clinical challenge remains the accomplishment of an efficient and safe therapeutic optio…
FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
